Healthcare-related research is largely regional. Put simply, this is because disease burdens differ between world regions. Even global burdens, such as ischaemic heart disease and cancer, display distinctive characteristics in certain regions that are not seen in others. Regional differences in infrastructure, resources and human capital further compound the differences seen, as they affect the way in which the local scientific community can interact with the local disease burden. As such, it seems fair to assume that healthcare-related research ought to be regionally distributed. Although translation of research between regions can sometimes be done, the larger the gap in infrastructure, resources or human capital between regions, the less likely it is that it can be adequately bridged. A recent example of this pertains to accepted life-saving treatment for sepsis in high-income settings, which had the opposite effect when implemented and evaluated in low-income Zambia. This regionality of clinical medicine is, however, not reflected in academic publishing; the impact of a journal is measured and understood by metrics that use the world as their denominator. Therefore, top medical journals are perceived to be relevant equally to all contexts and regions. However, there is a strong case to be made that this lack of granularity is deleterious, and that the creation of a regional impact metric would place clinicians, researchers, and libraries in a better position to understand which journals are relevant to their context and practice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813912 | PMC |
http://dx.doi.org/10.3332/ecancer.2018.ed78 | DOI Listing |
Database (Oxford)
January 2025
Rat Genome Database, Department of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, United States.
The Rat Genome Database (RGD) is a multispecies knowledgebase which integrates genetic, multiomic, phenotypic, and disease data across 10 mammalian species. To support cross-species, multiomics studies and to enhance and expand on data manually extracted from the biomedical literature by the RGD team of expert curators, RGD imports and integrates data from multiple sources. These include major databases and a substantial number of domain-specific resources, as well as direct submissions by individual researchers.
View Article and Find Full Text PDFJ Multidiscip Healthc
January 2025
Department of Pharmaceutics and Social Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia.
Introduction: Access to essential medicines is limited in developing countries mainly due to inefficiencies in health supply chain management, such as the absence of standard monitoring frameworks and poorly designed Logistics Management Information Systems (LMIS). Health supply chain managers need accurate and timely data for decision-making. However, routine health information systems suffer from poor data quality, reliance on paper-based reports, insufficient logistic formats, inadequate infrastructure, and limited human resources.
View Article and Find Full Text PDFDigit Health
January 2025
Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
The application of artificial intelligence (AI) to healthcare in Africa has the potential to transform productivity, diagnosis, disease surveillance, and resource allocation by improving accuracy and efficiency. However, to fully realize its benefits, it is necessary to consider issues concerning data privacy, equity, infrastructure integration, and ethical policy development. The use of these tools may improve the detection of diseases, the distribution of resources, and the continuity of care.
View Article and Find Full Text PDFFront Public Health
January 2025
School of Economics, Liaoning University, Shenyang, China.
Urban public health resilience has become a critical focus in the transition to high-quality development, especially in addressing increasing public health challenges. This study explores the role of artificial intelligence (AI) technology in enhancing urban public health resilience across 284 Chinese cities from 2011 to 2021. Using a comprehensive index based on resistance, recovery, and innovation dimensions, the study quantifies AI technology levels through patent applications and authorizations, further disaggregating these into invention, utility model, and design patents.
View Article and Find Full Text PDFBMC Public Health
January 2025
Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, People's Republic of China.
Background: Leukemia, a group of malignant tumors, has been a significant public health concern due to its high incidence and mortality rates. This study aimed to provide an in-depth analysis of the global leukemia burden from 1990 to 2021 using the Global Burden of Disease (GBD) database, focusing on trends in incidence, mortality, and Disability-Adjusted Life Years (DALYs) across different regions, genders, and age groups including forecasting future trends.
Methods: Data were sourced from the GBD study, utilizing the Global Health Data Exchange (GHDx) query tool.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!